UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000030732
Receipt No. R000035094
Official scientific title of the study Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial: Extended Follow-up Study
Date of disclosure of the study information 2018/02/02
Last modified on 2018/01/09 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial:
Extended Follow-up Study
Title of the study (Brief title) RESET:Extended Follow-up Study
Region
Japan

Condition
Condition Coronary Artery Disease
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the long-term efficacy and safety of cobalt chrome everolimus-eluting stent (CoCr-EES) of XIENCE V and 1st generation sirolimus-eluting stent (SES) of Cypher
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Any TLR
A composite of all-cause death and MI
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 3196 patients who participated in the RESET trial.
Key exclusion criteria Patients who refuse to participate.
Target sample size 3196

Research contact person
Name of lead principal investigator Takeshi Kimura
Organization Kyoto University Graduate School of Medicine
Division name Department of Cardiovascular Medicine
Address 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto
TEL 075-751-4255
Email taketaka@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Hiroki Shiomi
Organization Kyoto University Graduate School of Medicine
Division name Department of Cardiovascular Medicine
Address 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto
TEL 075-751-4255
Homepage URL
Email hishiomi@kuhp.kyoto-u.ac.jp

Sponsor
Institute Research Institute for Production Development
Institute
Department

Funding Source
Organization Abbott Vascular
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 02 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 12 Month 05 Day
Anticipated trial start date
2018 Year 01 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information This study is the extended follow-up study of the RESET randomized study.

Management information
Registered date
2018 Year 01 Month 09 Day
Last modified on
2018 Year 01 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035094